Researchers have discovered that nondeceptive placebos—placebos given with the full knowledge that they are placebos—can effectively manage stress, even when administered remotely. In a two-week randomized controlled trial, participants experiencing prolonged stress were divided into two groups: one group received nondeceptive placebos, while the other served as a control.

A new study shows that Cannabigerol (CBG) significantly reduces anxiety without the intoxicating effects of THC. The clinical trial found that 20 mg of CBG reduced anxiety and stress in participants, with memory enhancement as an unexpected benefit. The study highlights CBG’s potential as an alternative anxiety treatment. Further research is needed to confirm these findings and explore additional benefits.

A new study reveals that chronic and new anxiety are linked to a higher risk of dementia, while resolved anxiety shows no such association. Following 2,132 Australian individuals for 10 years, researchers found that chronic and new anxiety increased dementia risk by 2.8 and 3.2 times, respectively. Those whose anxiety began before age 70 faced even greater risks. The findings suggest that addressing anxiety could help prevent dementia.